Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
July 27, 1999
Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells
N Fortunati, M Becchis, M G Catalano, et al.
Hormone Research
|
January 1, 1996
Sex steroid-binding protein and its membrane receptor in estrogen-dependent breast cancer: biological and pathophysiological impact
N Fortunati, F Fissore, A Comba, et al.
Journal of Molecular Endocrinology
|
December 1, 1993
The hepatic receptor for sex steroid-binding protein: study on a non-malignant cell line (Chang liver)
N Fortunati, M Becchis, F Fissore, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 21, 1999
Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)
N Fortunati, F Fissore, A Fazzari, et al.
Endocrinology
|
February 1, 1996
Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase A
N Fortunati, F Fissore, A Fazzari, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 24, 2007
High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells
M G Catalano, L Costantino, N Fortunati, et al.
Breast Cancer Research and Treatment
|
March 10, 2010
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
N Fortunati, M G Catalano, F Marano, et al.
Molecular and Cellular Endocrinology
|
September 24, 2009
Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells
N Fortunati, S Bertino, L Costantino, et al.
Eating and Weight Disorders : EWD
|
October 23, 2012
Tumour necrosis factor alpha and oxidative stress as maintaining factors in the evolution of anorexia nervosa
E Agnello, G Malfi, A M Costantino, et al.
Cancer Genetics and Cytogenetics
|
December 20, 2000
Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability
P Ferro, M G Catalano, M Raineri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
The Journal of Steroid Biochemistry and Molecular Biology
|
July 27, 1999
Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells
N Fortunati, M Becchis, M G Catalano, et al.
Hormone Research
|
January 1, 1996
Sex steroid-binding protein and its membrane receptor in estrogen-dependent breast cancer: biological and pathophysiological impact
N Fortunati, F Fissore, A Comba, et al.
Journal of Molecular Endocrinology
|
December 1, 1993
The hepatic receptor for sex steroid-binding protein: study on a non-malignant cell line (Chang liver)
N Fortunati, M Becchis, F Fissore, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 21, 1999
Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)
N Fortunati, F Fissore, A Fazzari, et al.
Endocrinology
|
February 1, 1996
Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase A
N Fortunati, F Fissore, A Fazzari, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 24, 2007
High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells
M G Catalano, L Costantino, N Fortunati, et al.
Breast Cancer Research and Treatment
|
March 10, 2010
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
N Fortunati, M G Catalano, F Marano, et al.
Molecular and Cellular Endocrinology
|
September 24, 2009
Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells
N Fortunati, S Bertino, L Costantino, et al.
Eating and Weight Disorders : EWD
|
October 23, 2012
Tumour necrosis factor alpha and oxidative stress as maintaining factors in the evolution of anorexia nervosa
E Agnello, G Malfi, A M Costantino, et al.
Cancer Genetics and Cytogenetics
|
December 20, 2000
Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability
P Ferro, M G Catalano, M Raineri, et al.
Page
of 3